Skip to Content
Merck
  • Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish.

Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish.

Blood (2013-11-08)
A A Roger Thompson, Philip M Elks, Helen M Marriott, Suttida Eamsamarng, Kathryn R Higgins, Amy Lewis, Lynne Williams, Selina Parmar, Gary Shaw, Emmet E McGrath, Federico Formenti, Fredericus J Van Eeden, Vuokko L Kinnula, Christopher W Pugh, Ian Sabroe, David H Dockrell, Edwin R Chilvers, Peter A Robbins, Melanie J Percy, M Celeste Simon, Randall S Johnson, Stephen A Renshaw, Moira K B Whyte, Sarah R Walmsley
ABSTRACT

Neutrophil lifespan and function are regulated by hypoxia via components of the hypoxia inducible factor (HIF)/von Hippel Lindau/hydroxylase pathway, including specific roles for HIF-1α and prolyl hydroxylase-3. HIF-2α has both distinct and overlapping biological roles with HIF-1α and has not previously been studied in the context of neutrophil biology. We investigated the role of HIF-2α in regulating key neutrophil functions. Human and murine peripheral blood neutrophils expressed HIF-2α, with expression up-regulated by acute and chronic inflammatory stimuli and in disease-associated inflammatory neutrophil. HIF2A gain-of-function mutations resulted in a reduction in neutrophil apoptosis both ex vivo, through the study of patient cells, and in vivo in a zebrafish tail injury model. In contrast, HIF-2α-deficient murine inflammatory neutrophils displayed increased sensitivity to nitrosative stress induced apoptosis ex vivo and increased neutrophil apoptosis in vivo, resulting in a reduction in neutrophilic inflammation and reduced tissue injury. Expression of HIF-2α was temporally dissociated from HIF-1α in vivo and predominated in the resolution phase of inflammation. These data support a critical and selective role for HIF-2α in persistence of neutrophilic inflammation and provide a platform to dissect the therapeutic utility of targeting HIF-2α in chronic inflammatory diseases.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Lysozyme from chicken egg white, 10 mg/mL
Sigma-Aldrich
Lysozyme from human neutrophils, ≥95% (SDS-PAGE), lyophilized powder, ≥100,000 units/mg protein (E1%/280)
Sigma-Aldrich
Lysozyme human, Lysobac, recombinant, expressed in rice, ≥100,000 units/mg protein, lyophilized powder
Sigma-Aldrich
Lysozyme from chicken egg white, BioUltra, lyophilized powder, ≥98% (SDS-PAGE), ≥40,000 units/mg protein
Sigma-Aldrich
Lysozyme chloride form from chicken egg white, Grade VI, ≥35,000 units/mg protein (E1%/282)
Sigma-Aldrich
Lysozyme from chicken egg white, powder or granules, ≥90 %, ≥39,000 units/mg protein
Sigma-Aldrich
Lysozyme from chicken egg white, For use as a marker in SDS-PAGE
Sigma-Aldrich
Lysozyme from chicken egg white, aseptically filled
Sigma-Aldrich
Lysozyme from chicken egg white, powder (crystalline), ~70000 U/mg
Sigma-Aldrich
Lysozyme from chicken egg white, dialyzed, lyophilized, powder, ~100000 U/mg
Supelco
Lysozyme from chicken egg white, VETRANAL®, analytical standard